Endometriosis at genital & extragenital localization (stage I-IV), prostatic cancer w/ metastases.
Dosage/Direction for Use
Endometriosis As principal treatment during 1st 5 days of menstrual cycle, given in single SC or IM inj, renewed every 4 wk. Max duration: 6 mth. Prostate carcinoma 3.75 mg as single SC/IM inj mthly.
Contraindications
Hypersensitivity to GnRH or its analogues. Vag bleeding of undetermined origin. Pregnancy & lactation.
Special Precautions
Women w/ known risk factors for decreased bone mineral content.
Adverse Reactions
Hypoestrogenism, hot flushes, blurred vision, decreased libido, dizziness, edema, headache, vag dryness, emotional instability, myalgia, arthralgia, bone pain, bone density modification.
Sign Out
